Trial intelligence / Profile preview

Intra-articular Morphine vs Methylprednisolone for Knee Osteoarthritis

NCT06163755Phase 2Withdrawn

Sponsor
Henry Ford Health
Start
Jan 2018
Primary completion
Dec 2018
Modality
Small Molecules
01

Overview

A Phase 2 trial of morphine in osteoarthritis (OA), sponsored by Henry Ford Health. Planned start Jan 2018; status: withdrawn.

02

Drugs

morphine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06163755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06163755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call